🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well trabedersen (OT-101) in combination with...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-01
Trial ID
NCT05935774
In this national Phase I dose-escalation study the safety and tolerability ...
Status
Completed
Location
Universitätsmedizin Berlin Charité
Start Date
2005-01
Trial ID
NCT00844064
Treatments Being Tested
Primary Objective is to evaluate the safety and efficacy of OT-101+Artemisi...
Status
Unknown
Location
Praxis Pesquisa Medica S / S Ltda
Start Date
2021-04
Trial ID
NCT04801017
Treatments Being Tested
The goal of this clinical trial is to: 1) evaluate the safety and recommend...
Status
Recruiting
Location
University of Nebraska Medical Center
Start Date
2025-05-12
Trial ID
NCT06579196
Treatments Being Tested
In this multinational Phase III study the efficacy and safety of 10 µM AP 1...
Status
Terminated
Location
NJ Neuroscience Institute; JFK Medical Center
Start Date
2008-12
Trial ID
NCT00761280
In this multinational dose finding Phase IIb study the efficacy and safety ...
Status
Completed
Location
Universitätsklinik Innsbruck; Abteilung für Neurochirurgie
Start Date
2003-04
Trial ID
NCT00431561